Wednesday Aug 6
Improved Quality of Life After One Year With an Invasive Versus a...
The quality of evidence for invasive revascularization in intermittent claudication is low or very low.
Pluristem Therapeutics Initiates South Korean Arm of Multinational...
Pluristem Therapeutics Inc. , a leading developer of placenta-based cell therapies, today announced the initiation of South Korean sites in the Phase II study assessing PLacental eXpanded cells in the treatment of intermittent claudication .
Six-Minute Walk Is a Better Outcome Measure Than Treadmill Walking...
From the Departments of Medicine , Preventive Medicine , and Surgery , Northwestern University's Feinberg School of Medicine, Chicago, IL; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore ; Department of Family and Preventive Medicine University of California at San Diego, San Diego ; and ... (more)